# AIMMED

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aimmed

- Industry: Healthcare
- Headquarters: Seoul, South Korea
- Website: www.aimmed.co.kr
- Total disclosed funding: $15M
- Latest round: Series A (Oct 6, 2021)
- Investors on record: 2

## About

In 1999, the company was founded under the name Aim Medical Center Co., Ltd. In 2001, the company launched its BizCare service and InsuCare service. In 2002, the company changed its name to AIMMED. In 2003, the company was acquired by Medipost Co., Ltd., and two years later, it launched the Mom&Baby home care service. From 2006 to 2008, the company launched a series of healthcare services including u-Healthcare service, Homecare, MetLife Life Healthcare, and CJ Group employee health management. In 2009, the company reached a partnership with Samsung, launching the Samsung Card medical support service. In 2012, the company's voice-recognition-tech-based remote health management system was registered as a patent. In 2015, the company merged with Ace Meditech Co., Ltd., a diagnostic reagent distribution company. In 2016, the company launched its chronic disease management app Recover.

The company provides healthcare services called InsuCare, which range from normal healthcare services to treatment support. It also provides health management services for disease prevention and health promotion, called BizCare. Additionally, EAP (Employee Assistance Program), mental care apps, a Patient Centered Business (PCB), as well as senior care services.

## Funding rounds

- Series A, Oct 6, 2021, $15M — Korea Investment Private Equity, T.S. Investment

## Investors

- Korea Investment Private Equity (https://capitalatlas.ai/funds/korea-investment-private-equity) — Series A
- T.S. Investment (https://capitalatlas.ai/funds/t-s-investment) — Series A